Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant expression systems for allergen vaccines.

Mohan B Singh1, Prem L Bhalla

  • 1Plant Molecular Biology and Biotechnology Laboratory, Australian Research Council Centre of Excellence for Integrative Legume Research, Institute of Land and Food Resources, The University of Melbourne, Parkville, Vic 3010, Australia. mohan@unimelb.edu.au

Inflammation & Allergy Drug Targets
|April 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deciphering the Vulnerability of Pollen to Heat Stress for Securing Crop Yields in a Warming Climate.

Plant, cell & environment·2024
Same author

Identifying long non-coding RNAs involved in heat stress response during wheat pollen development.

Frontiers in plant science·2024
Same author

Overexpression of GmPIF4b affects morpho-physiological traits to reduce heat-induced grain loss in soybean.

Plant physiology and biochemistry : PPB·2023
Same author

Biological Parts for Engineering Abiotic Stress Tolerance in Plants.

Biodesign research·2023
Same author

Pokkali: A Naturally Evolved Salt-Tolerant Rice Shows a Distinguished Set of lncRNAs Possibly Contributing to the Tolerant Phenotype.

International journal of molecular sciences·2023
Same author

Circular RNAs modulate the floral fate acquisition in soybean shoot apical meristem.

BMC plant biology·2023

Future allergy vaccines may use engineered allergens to prevent anaphylaxis. This review compares microbial, yeast, mammalian, and plant systems for producing these recombinant allergens, highlighting plant-based systems as promising for safety and cost-effectiveness.

Area of Science:

  • Biotechnology
  • Immunology
  • Vaccine Development

Background:

  • Allergen immunotherapy aims to reduce allergic reactions using modified allergens.
  • Engineered allergens must be produced efficiently for vaccine development.
  • Current production systems have limitations in cost, scalability, and post-translational modifications.

Purpose of the Study:

  • To review and compare various heterologous systems for recombinant allergen production.
  • To identify the most suitable systems for developing safe and effective allergy vaccines.

Main Methods:

  • Comparative analysis of microbial, yeast, mammalian, and plant-based expression systems.
  • Evaluation of advantages and disadvantages of each system regarding cost, scalability, and protein modification.

Related Experiment Videos

Main Results:

  • Microbial systems are cost-effective but lack post-translational modifications.
  • Yeast systems can over-glycosylate proteins.
  • Mammalian systems provide proper modifications but are expensive.
  • Plant-based systems offer a balance of cost-effectiveness, scalability, and appropriate post-translational modifications.

Conclusions:

  • Plant-based systems are emerging as a highly attractive option for recombinant allergen production.
  • These systems offer advantages in post-translational processing, cost, scalability, and safety for future allergy vaccines.